Science Applications International: Increased Revenue, EPS and Margin Outlook Clouded by Slumping Backlog and Weak Book-to-bill By Ivo Kolchev Fundamental Analysis Read More
McKesson: Top-and-bottom-line Guidance Boosted on Strength in U.S Pharmaceutical and Prescription Technology Solutions Segments By Ivo Kolchev Fundamental Analysis Read More
The Role of Supply Chain Data in Capturing and Mitigating Risk in the Defense Sector By Vladi Nikolov Fundamental Analysis Read More
Pfizer: Performance Trough in Q2 on Weak COVID-19 Product Sales and Elevated Product Launch Costs By Ivo Kolchev Fundamental Analysis Read More
Booz Allen Hamilton: Strongest Revenue Growth Since 2010 IPO Obscured by $377.5 Cash Flow Hit from Department of Justice Settlement By Ivo Kolchev Fundamental Analysis Read More
Top Healthcare Government Contractors: Polarized H1 2023 Results as Decline in COVID-19 Revenue Hammers Drugmakers While Rest of the Industry Grows in the Low Double-digits By Ivo Kolchev Fundamental Analysis Read More
Top IT & Services Government Contractors: Low-single Digit Sales Growth and Persistent Margins in H1 2023, with Temporary Revenue Weakness Largely Limited to Hardware IT Companies By Ivo Kolchev Fundamental Analysis Read More